Latest News about IONS
Recent news which mentions IONS
From Benzinga
FDA Accepts Biogen's Submission For Neurodegenerative Disease Drug Under Priority Review
July 26, 2022
From Benzinga
From Benzinga
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
From InvestorPlace
From Benzinga
From Benzinga
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
From InvestorPlace
Cathie Wood's Ark Invest Sheds $35M In 3D Printing Company Stratasys — What It Bought Instead
July 06, 2022
From Benzinga
EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform
June 30, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
5 Cathie Wood Stocks to Buy in June
June 09, 2022
From InvestorPlace
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
From InvestorPlace
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
Ionis Pharma - AstraZeneca Antisense Medicine Met Its Primary, Secondary Goals To Lower Cholesterol
April 04, 2022
From Benzinga
From Benzinga
Why Cramer Likes Ferguson And Stanley Black & Decker
March 25, 2022
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
Ionis Pharma Announces Publication Of Positive Donidalorsen Data For Angioedema Attacks
March 17, 2022
Tickers
IONS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.